Charles River Laboratories

Drug discovery services market to reach $16.6B in 2015

Monday, December 10, 2012 10:09 AM

A new report by visiongain, an independent media company based in London, predicts that the world market for drug discovery outsourcing will reach $16.6 billion in 2015. That revenue forecast and others appear in “DrugDiscovery Outsourcing: World Market 2013-2023,” published in November 2012.

More... »

Charles River to acquire Vital River, expands research models business

Thursday, November 1, 2012 09:28 AM

Charles River Laboratories International, a global provider of research products and services, has entered into an agreement to acquire 75% ownership of Vital River, a Chinese commercial provider of research models and related services.

More... »

Charles River Labs, AZ enter strategic partnership

Monday, October 22, 2012 10:43 AM

AstraZeneca, a global biopharmaceutical company, has selected Charles River Laboratories International, a global provider of research products and services, as its preferred strategic partner for outsourced regulated safety assessment and development DMPK (drug metabolism and pharmacokinetics).

More... »

Charles River opens new biomedical diagnostic facility

Friday, September 7, 2012 12:30 PM

Charles River Laboratories, a global preclinical CRO, has opened its new biomedical diagnostic testing facility in Wilmington, Mass.

More... »

Charles River acquires Accugenix

Thursday, August 30, 2012 10:35 AM

Charles River Laboratories International, a global provider of research products and services, has acquired Accugenix, a global provider of cGMP-compliant contract microbial identification testing, for approximately $17 million in cash.

More... »

Charles River and Metabolon partner on cancer research

Friday, April 6, 2012 10:54 AM

Charles River Discovery Services is partnering with Metabolon, a diagnostic products and services company based in Research Triangle Park, N.C., to enhance oncology research.

More... »

Charles River Labs to license EMD Millipore’s TrueSpike technology

Friday, March 2, 2012 06:00 AM

EMD Millipore, the life science division of Merck based in Billerica, Mass., will partner with Charles River Laboratories to exclusively license the TrueSpike technology, which reduces protein content of virus preparations and increases predictability of validation studies.

More... »

Charles River posts quarterly and full-year 2011 results

Friday, February 17, 2012 01:40 PM

Charles River Laboratories has reported financial results for the fourth quarter and for full-year 2011.

More... »

Charles River Labs launches online community Eureka

Thursday, January 26, 2012 10:59 AM

Charles River Laboratories has launched Eureka, an online community for scientists “to explore, connect and share big ideas.” The site profiles scientific professionals at Charles River Labs and welcomes industry experts to share their research and opinions on industry topics and questions.

More... »

Charles River provides financial guidance for 2012

Thursday, December 15, 2011 02:59 PM

Charles River Laboratories International has provided guidance for 2012 and updated guidance for 2011. James C. Foster, Chairman, president and chief executive officer, said, “We made significant progress in 2011 on our four key initiatives, which include operating margin expansion, improved free cash flow, disciplined investment in existing growth businesses, and returning value to shareholders. In 2012, we will maintain our focus on these initiatives and on stimulating sales growth.”

More... »